Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

Clinical trial NCT00003294 · COMPLETED

Trial details

NCT number: NCT00003294
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Lymphoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-05-01
Primary completion: 1999-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.